2022.Apr.18

Announcement of the expiration of the Company's 2022 cash capital increase call period and the issuance of stocks

1.Date of occurrence of the event:2022/04/18 2.Company name:OBI Pharma Inc. 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office 4.Reciprocal shareholding ratios:Not applicable 5.Cause of occurrence:The Company’s 2022 cash capital increase, with a call eriod of payment from 2022/3/18 to 2022/4/18 15:30, ends today. 6.Countermeasures: (1)Shareholders who haven’t paid up for subscription during […]

HOMEWhat’s NewAnnouncementsAnnouncement of the expiration of the Company’s 2022 cash capital increase call period and the issuance of stocks

Back to List

This article is password protected.

To view the content, please enter your password in the field below

2022.Apr.06

AEMPS of Spain revokes previous approval for the Active Cancer Immunotherapy, OBI-822, to proceed to Phase III Clinical Trial

2022.May.03

OBI-999 ”Conjugated Biological Molecules, Pharmaceutical Compositions and Methods“ Was Granted By Taiwan Intellectual Property Office